drug

lasmiditan

1 story · latest Sep 4, 2026

Status: Investigational
Code: LY573144
Trials: 1 registered trial in coverage

Relationships

Developed by Eli Lilly

Timeline

Lilly posts Phase 3 orforglipron results; two more programs report terminated-trial data

Sep 4Weekly roundup, 7 itemsEli Lilly lasmiditan

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.